Search tips
Search criteria 


Logo of aacPermissionsJournals.ASM.orgJournalAAC ArticleJournal InfoAuthorsReviewers
Antimicrob Agents Chemother. 1988 May; 32(5): 642–645.
PMCID: PMC172245

In vitro susceptibility of Bacillus spp. to selected antimicrobial agents.


Although often dismissed as contaminants when isolated from blood cultures, Bacillus spp. are increasingly recognized as capable of causing serious systemic infections. As part of a clinical-microbiological study, 89 strains of Bacillus spp. isolated from clinical blood cultures between 1981 and 1985 had their species determined and were tested for antimicrobial agent susceptibility to 18 antibiotics. Species of isolates were determined by the API 50CH and API 20E systems. Bacillus cereus (54 strains) was the most common species isolated, followed by B. megaterium (13 strains), B. polymyxa (5 strains), B. pumilus (4 strains), B. subtilis (4 strains), B. circulans (3 strains), B. amyloliquefaciens (2 strains), B. licheniformis (1 strain), and Bacillus spp. (3 strains). Microdilution MIC susceptibility tests revealed all B. cereus strains to be susceptible to imipenem, vancomycin, chloramphenicol, gentamicin, and ciprofloxacin. Non-B. cereus strains were most susceptible to imipenem, vancomycin, LY146032, and ciprofloxacin. Disk susceptibility testing suggested that B. cereus was rarely susceptible to penicillins, semisynthetic penicillins, or cephalosporins with the exception of mezlocillin. In contrast, many non-B. cereus strains were susceptible to penicillins, semisynthetic penicillins, and cephalosporins, but marked variability was noted among species.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (743K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Coonrod JD, Leadley PJ, Eickhoff TC. Antibiotic susceptibility of Bacillus species. J Infect Dis. 1971 Jan;123(1):102–105. [PubMed]
  • Cotton DJ, Gill VJ, Marshall DJ, Gress J, Thaler M, Pizzo PA. Clinical features and therapeutic interventions in 17 cases of Bacillus bacteremia in an immunosuppressed patient population. J Clin Microbiol. 1987 Apr;25(4):672–674. [PMC free article] [PubMed]
  • Davey RT, Jr, Tauber WB. Posttraumatic endophthalmitis: the emerging role of Bacillus cereus infection. Rev Infect Dis. 1987 Jan-Feb;9(1):110–123. [PubMed]
  • FARRAR WE., Jr Serious infections due to "non-pathogenic" organisms of the genus Bacillus. Review of their status as pathogens. Am J Med. 1963 Jan;34:134–141. [PubMed]
  • Ihde DC, Armstrong D. Clinical spectrum of infection due to Bacillus species. Am J Med. 1973 Dec;55(6):839–845. [PubMed]
  • Logan NA, Berkeley RC. Identification of Bacillus strains using the API system. J Gen Microbiol. 1984 Jul;130(7):1871–1882. [PubMed]
  • O'Day DM, Smith RS, Gregg CR, Turnbull PC, Head WS, Ives JA, Ho PC. The problem of bacillus species infection with special emphasis on the virulence of Bacillus cereus. Ophthalmology. 1981 Aug;88(8):833–838. [PubMed]
  • Pearson HE. Human infections caused by organisms of the bacillus species. Am J Clin Pathol. 1970 Apr;53(4):506–515. [PubMed]
  • Saleh RA, Schorin MA. Bacillus sp. sepsis associated with Hickman catheters in patients with neoplastic disease. Pediatr Infect Dis J. 1987 Sep;6(9):851–856. [PubMed]
  • Siegman-Igra Y, Lavochkin J, Schwartz D, Konforti N. Meningitis and bacteremia due to Bacillus cereus. A case report and a review of Bacillus infections. Isr J Med Sci. 1983 Jun;19(6):546–551. [PubMed]
  • Sliman R, Rehm S, Shlaes DM. Serious infections caused by Bacillus species. Medicine (Baltimore) 1987 May;66(3):218–223. [PubMed]
  • Tuazon CU, Murray HW, Levy C, Solny MN, Curtin JA, Sheagren JN. Serious infections from Bacillus sp. JAMA. 1979 Mar 16;241(11):1137–1140. [PubMed]
  • Turnbull PC, Kramer JM. Non-gastrointestinal Bacillus cereus infections: an analysis of exotoxin production by strains isolated over a two-year period. J Clin Pathol. 1983 Oct;36(10):1091–1096. [PMC free article] [PubMed]
  • Wiedermann BL. Non-anthrax Bacillus infections in children. Pediatr Infect Dis J. 1987 Feb;6(2):218–220. [PubMed]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)